Delivery of oligonucleotide‐based therapeutics: challenges and opportunities

Suzan M Hammond, Annemieke Aartsma‐Rus, Sandra Alves, Sven E Borgos, Ronald A M Buijsen, Rob W J Collin, Giuseppina Covello, Michela A Denti, Lourdes R Desviat, Lucía Echevarría, Camilla Foged, Gisela Gaina, Alejandro Garanto, Aurelie T Goyenvalle, Magdalena Guzowska, Irina Holodnuka, David R Jones, Sabine Krause, Taavi Lehto, Marisol Montolio, Willeke Van Roon‐Mom, Virginia Arechavala‐Gomeza

Open source

DOI: 10.15252/emmm.202013243
Published: 2021-04-06
Container: EMBO Molecular Medicine
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.15252/emmm.202013243,
  title = {Delivery of oligonucleotide‐based therapeutics: challenges and opportunities},
  author = {Suzan M Hammond and Annemieke Aartsma‐Rus and Sandra Alves and Sven E Borgos and Ronald A M Buijsen and Rob W J Collin and Giuseppina Covello and Michela A Denti and Lourdes R Desviat and Lucía Echevarría and Camilla Foged and Gisela Gaina and Alejandro Garanto and Aurelie T Goyenvalle and Magdalena Guzowska and Irina Holodnuka and David R Jones and Sabine Krause and Taavi Lehto and Marisol Montolio and Willeke Van Roon‐Mom and Virginia Arechavala‐Gomeza},
  year = {2021},
  journal = {EMBO Molecular Medicine},
  doi = {10.15252/emmm.202013243},
  url = {https://doi.org/10.15252/emmm.202013243}
}

RIS

TY  - JOUR
TI  - Delivery of oligonucleotide‐based therapeutics: challenges and opportunities
AU  - Suzan M Hammond
AU  - Annemieke Aartsma‐Rus
AU  - Sandra Alves
AU  - Sven E Borgos
AU  - Ronald A M Buijsen
AU  - Rob W J Collin
AU  - Giuseppina Covello
AU  - Michela A Denti
AU  - Lourdes R Desviat
AU  - Lucía Echevarría
AU  - Camilla Foged
AU  - Gisela Gaina
AU  - Alejandro Garanto
AU  - Aurelie T Goyenvalle
AU  - Magdalena Guzowska
AU  - Irina Holodnuka
AU  - David R Jones
AU  - Sabine Krause
AU  - Taavi Lehto
AU  - Marisol Montolio
AU  - Willeke Van Roon‐Mom
AU  - Virginia Arechavala‐Gomeza
PY  - 2021
JO  - EMBO Molecular Medicine
DO  - 10.15252/emmm.202013243
UR  - https://doi.org/10.15252/emmm.202013243
ER  -

APA

Hammond, S. M., Aartsma‐Rus, A., Alves, S., Borgos, S. E., Buijsen, R. A. M., Collin, R. W. J., Covello, G., Denti, M. A., Desviat, L. R., Echevarría, L., Foged, C., Gaina, G., Garanto, A., Goyenvalle, A. T., Guzowska, M., Holodnuka, I., Jones, D. R., Krause, S., Lehto, T., Montolio, M., Roon‐Mom, W. V., & Arechavala‐Gomeza, V. (2021). Delivery of oligonucleotide‐based therapeutics: challenges and opportunities. EMBO Molecular Medicine. https://doi.org/10.15252/emmm.202013243

Source records

crossref · retrieved 2026-09-26T16:13:17.200Z